Abstract: The present invention discloses a gel formulation of aceclofenac alone or in combination with ingredient which act as anti-inflammatory agent and its process for preparation wherein aceclofenac is aceclofenac or its pharmaceutically acceptable salts or derivatives.
| # | Name | Date |
|---|---|---|
| 1 | Form 26 [19-12-2015(online)].pdf | 2015-12-19 |
| 2 | OTHERS [15-03-2016(online)].pdf | 2016-03-15 |
| 3 | Examination Report Reply Recieved [15-03-2016(online)].pdf | 2016-03-15 |
| 4 | Description(Complete) [15-03-2016(online)].pdf | 2016-03-15 |
| 5 | Claims [15-03-2016(online)].pdf | 2016-03-15 |
| 6 | 1381-MUM-2009_EXAMREPORT.pdf | 2018-08-10 |
| 7 | 1381-MUM-2009-FORM 5(7-2-2011).pdf | 2018-08-10 |
| 8 | 1381-mum-2009-form 3.pdf | 2018-08-10 |
| 9 | 1381-MUM-2009-FORM 3(7-2-2011).pdf | 2018-08-10 |
| 10 | 1381-mum-2009-form 26.pdf | 2018-08-10 |
| 11 | 1381-mum-2009-form 2.pdf | 2018-08-10 |
| 13 | 1381-mum-2009-form 2(title page).pdf | 2018-08-10 |
| 14 | 1381-MUM-2009-FORM 18(3-11-2011).pdf | 2018-08-10 |
| 15 | 1381-mum-2009-form 1.pdf | 2018-08-10 |
| 16 | 1381-MUM-2009-FORM 1(7-2-2011).pdf | 2018-08-10 |
| 17 | 1381-mum-2009-description(complete).pdf | 2018-08-10 |
| 19 | 1381-mum-2009-correspondence.pdf | 2018-08-10 |
| 20 | 1381-MUM-2009-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(1-3-2017).pdf | 2018-08-10 |
| 21 | 1381-MUM-2009-CORRESPONDENCE(IPO)-(FER)-(16-3-2015).pdf | 2018-08-10 |
| 22 | 1381-MUM-2009-CORRESPONDENCE(IPO)-(6-10-2009).pdf | 2018-08-10 |
| 23 | 1381-MUM-2009-CORRESPONDENCE(7-2-2011).pdf | 2018-08-10 |
| 24 | 1381-MUM-2009-CORRESPONDENCE(3-11-2011).pdf | 2018-08-10 |
| 25 | 1381-mum-2009-claims.pdf | 2018-08-10 |
| 27 | 1381-mum-2009-abstract.pdf | 2018-08-10 |